Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?
暂无分享,去创建一个
C. Prefaut | J. Cristol | M. Hayot | D. Simar | A. Couillard | C. Koechlin | H. Bellet
[1] A. Bast,et al. Oxidant metabolism in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[2] L. Koenderman,et al. Systemic inflammation in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[3] F. Maltais,et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[4] E. Wouters,et al. ROS in the local and systemic pathogenesis of COPD. , 2003, Free radical biology & medicine.
[5] M. Mador,et al. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[6] V. Callot,et al. Helium-3 MRI diffusion coefficient: correlation to morphometry in a model of mild emphysema , 2003, European Respiratory Journal.
[7] S. Hurd,et al. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.
[8] S. Hussain,et al. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory cell and molecular biology.
[9] François Maltais,et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[10] 유상준,et al. Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[11] A. Varray,et al. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients , 2002, European Respiratory Journal.
[12] Y. Lacasse,et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[13] M. Mador. Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[14] W. Bailey,et al. Global initiative for chronic obstructive lung disease. , 2002, Journal of cardiopulmonary rehabilitation.
[15] J. Taguchi,et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. , 2002, Atherosclerosis.
[16] C. Delcourt,et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] J. Barberà,et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[18] S. Hurd,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[19] M. Janiszewski,et al. Inhibition of vascular NADH/NADPH oxidase activity by thiol reagents: lack of correlation with cellular glutathione redox status. , 2000, Free radical biology & medicine.
[20] P. Leuenberger,et al. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. , 2000, Clinical therapeutics.
[21] J. Viña,et al. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] W. MacNee,et al. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[23] D. Postma,et al. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. , 1999, American journal of respiratory and critical care medicine.
[24] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[25] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[26] Kelly Gs. Clinical applications of N-acetylcysteine. , 1998 .
[27] A. Varray,et al. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. , 1998, Chest.
[28] A. Varray,et al. Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary disease. , 1997, Journal of cardiopulmonary rehabilitation.
[29] J. Sastre,et al. Exercise causes blood glutathione oxidation in chronic obstructive pulmonary disease: prevention by O2 therapy. , 1996, Journal of applied physiology.
[30] C. Léger,et al. Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation , 1995 .
[31] M. Reid,et al. N-acetylcysteine inhibits muscle fatigue in humans. , 1994, The Journal of clinical investigation.
[32] P. Chanez,et al. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. , 1994, The European respiratory journal.
[33] W. MacNee,et al. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. , 1994, Thorax.
[34] B. Halliwell,et al. Lipid peroxidation: its mechanism, measurement, and significance. , 1993, The American journal of clinical nutrition.
[35] M. Holdiness. Clinical Pharmacokinetics of N-Acetylcysteine , 1991, Clinical pharmacokinetics.
[36] G. Sjøgaard,et al. Dynamic knee extension as model for study of isolated exercising muscle in humans. , 1985, Journal of applied physiology.
[37] G. Brooks,et al. Free radicals and tissue damage produced by exercise. , 1982, Biochemical and biophysical research communications.
[38] K. Yagi,et al. A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.
[39] C. Sen,et al. Handbook of oxidants and antioxidants in exercise , 2000 .
[40] E. Wouters,et al. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. , 2000, American journal of respiratory and critical care medicine.
[41] Derick Han,et al. Part VII • Chapter 17 – Oxidative stress indices: analytical aspects and significance , 2000 .
[42] M. Reid,et al. Part IX • Chapter 22 – Muscle fatigue: mechanisms and regulation , 2000 .
[43] C. Rice-Evans,et al. Total antioxidant status in plasma and body fluids. , 1994, Methods in enzymology.